High-Tech radiotherapy for primary prostate cancers and synchronous other tumor in elderly
Journal: Journal of Clinical Images and Medical Case Reports (Vol.2, No. 3)Publication Date: 2021-06-30
Authors : Alessia Surgo; Ilaria Bonaparte; Fabiana Gregucci; Roberta Carbonara; Maria Paola Ciliberti; Morena Caliandro; Elena Ludovico; Roberto Calbi; Alessandro Verbo; Vincenzo D'Angelo; Marcello Scarcia;
Page : 1-4
Keywords : : Synchronous cancers; Elderly; Treatment; Radiotherapy; Multidisciplinary evaluation.;
Abstract
Aims: To report feasibility and efficacy of high-tech Radiotherapy (RT) for the treatment of synchronous Multiple Primary Malignancies (sMPM) for elderly patients with primary Prostate Cancer (PC). Methods: Two elderly patients with PC and synchronous Anal Cancer (AC) and sacrum chordoma, respectively, were described. The first one was treated with radical radio-chemotherapy. A total dose of 70 Gy / 65.5 Gy (28 fractions) was prescribed to prostate/ seminal vesicles, and concomitantly, 56 Gy / 50.4 Gy / 45 Gy were prescribed to tumor, anal canal/mesorectum/pelvic nodes, and inguinal nodes, respectively. For the second case, after resection of chordoma, adjuvant and prostate radical RT (65.5 Gy / 70 Gy) in 28 fractions were used. In both cases, Volumetric-Arc RT was performed. Results: Patients completed the planned treatment without severe toxicities. After a median follow-up of 12 months, no sign of PC and a controlled/reduction of chordoma/AC were observed. Conclusion: High-tech RT is safe and effective for sMPM elderly patients
Other Latest Articles
- Efficacy and safety of Chinese herbal medicine longdanxiegan decoction combined with val-acyclovir in herpes zoster: A systematic review and mate-analysis
- Autoimmune hepatitis: Side effect of infliximab perfusion
- Acute myocardial infarction and allergy, causal or casual relationship?
- Mediastinal eggshell calcifications
- Cronkhite-Canada syndrome with hypothyroidism: Clinical, endoscopic and pathologic pitfalls
Last modified: 2021-07-14 09:49:16